Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses

por Langreder, Nora, Schäckermann, Dorina, Meier, Doris, Becker, Marlies, Schubert, Maren, Dübel, Stefan, Reinard, Thomas, Figge-Wegener, Stefanie, Roßbach, Kristine, Bäumer, Wolfgang, Ladel, Simone, Hust, Michael
Publicado 2023

Baculovirus-free insect cell expression system for high yield antibody and antigen production

por Korn, Janin, Schäckermann, Dorina, Kirmann, Toni, Bertoglio, Federico, Steinke, Stephan, Heisig, Janyn, Ruschig, Maximilian, Rojas, Gertrudis, Langreder, Nora, Wenzel, Esther Veronika, Roth, Kristian Daniel Ralph, Becker, Marlies, Meier, Doris, van den Heuvel, Joop, Hust, Michael, Dübel, Stefan, Schubert, Maren
Publicado 2020

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

por Roth, Kristian Daniel Ralph, Wenzel, Esther Veronika, Ruschig, Maximilian, Steinke, Stephan, Langreder, Nora, Heine, Philip Alexander, Schneider, Kai-Thomas, Ballmann, Rico, Fühner, Viola, Kuhn, Philipp, Schirrmann, Thomas, Frenzel, André, Dübel, Stefan, Schubert, Maren, Moreira, Gustavo Marçal Schmidt Garcia, Bertoglio, Federico, Russo, Giulio, Hust, Michael
Publicado 2021

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

por Bertoglio, Federico, Meier, Doris, Langreder, Nora, Steinke, Stephan, Rand, Ulfert, Simonelli, Luca, Heine, Philip Alexander, Ballmann, Rico, Schneider, Kai-Thomas, Roth, Kristian Daniel Ralph, Ruschig, Maximilian, Riese, Peggy, Eschke, Kathrin, Kim, Yeonsu, Schäckermann, Dorina, Pedotti, Mattia, Kuhn, Philipp, Zock-Emmenthal, Susanne, Wöhrle, Johannes, Kilb, Normann, Herz, Tobias, Becker, Marlies, Grasshoff, Martina, Wenzel, Esther Veronika, Russo, Giulio, Kröger, Andrea, Brunotte, Linda, Ludwig, Stephan, Fühner, Viola, Krämer, Stefan Daniel, Dübel, Stefan, Varani, Luca, Roth, Günter, Čičin-Šain, Luka, Schubert, Maren, Hust, Michael
Publicado 2021

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

por Bertoglio, Federico, Fühner, Viola, Ruschig, Maximilian, Heine, Philip Alexander, Abassi, Leila, Klünemann, Thomas, Rand, Ulfert, Meier, Doris, Langreder, Nora, Steinke, Stephan, Ballmann, Rico, Schneider, Kai-Thomas, Roth, Kristian Daniel Ralph, Kuhn, Philipp, Riese, Peggy, Schäckermann, Dorina, Korn, Janin, Koch, Allan, Chaudhry, M. Zeeshan, Eschke, Kathrin, Kim, Yeonsu, Zock-Emmenthal, Susanne, Becker, Marlies, Scholz, Margitta, Moreira, Gustavo Marçal Schmidt Garcia, Wenzel, Esther Veronika, Russo, Giulio, Garritsen, Hendrikus S.P., Casu, Sebastian, Gerstner, Andreas, Roth, Günter, Adler, Julia, Trimpert, Jakob, Hermann, Andreas, Schirrmann, Thomas, Dübel, Stefan, Frenzel, André, Van den Heuvel, Joop, Čičin-Šain, Luka, Schubert, Maren, Hust, Michael
Publicado 2021